APC-366 tryptase inhibitor data

ARRS announced that a Phase IIa trial of APC-366 showed improvement in 8 of 12 patients with

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE